What to buy Financial News

2023 closed as a solid year for stock markets worldwide as bets that the Fed will start lowering interest rates as soon as early 2024 prompted investors back to risk assets after a more than forgettable 2022.

Ashi Anand, Founder & CEO, IME Capital, says “we are seeing a larger risk on trade, FII flows are starting to come back in. It is really the context of the current strength in metals. But from a slightly longer-term perspective, the Chinese economy is really struggling and importantly, it is the housing sector in China which is really struggling the most. Just two days ago, a Chinese developer went bankrupt. Now, China has been the core driver of global demand for metals and if the biggest demand driver is really going to be weak, it is really difficult to build any kind of longer-term fundamental call on at least the core metals.” A lot of interest in the IPO market and considering you track this space closely, any business that you have liked, any IPO that you have subscribed to? Ashi Anand: Yes, we are tracking the IPO space. There are certain interesting IPOs coming up. There are certain D2C brands which are coming up. There are certain other digital platforms. So, it is a space that we are tracking. The only problem is the IPO market is probably a bit too hot. Participation is probably being too high. There is a large amount of IPOs which probably are not of that high quality seeing very large subscription numbers.

Shiba Inu (SHIB) and Retik Finance (RETIK) both have unique qualities to the table, each with its own set of advantages and considerations. Let’s delve into the factors that might influence your decision on whether to buy Shiba Inu or Retik Finance before Christmas.

Shibani Sircar Kurian, Senior EVP, Fund Manager & Head -Equity Research, Kotak Mahindra AMC, says focus will be towards the slightly larger PSU banks given their ability to defend market share as well as their ability to raise capital which will again help in terms of loan growth as well as deposit growth. The auto pack is fairly well placed. There are pockets where growth remains strong, margins are improving because lower commodity costs continue to play out and in terms of portfolio positioning in the auto and auto ancillaries space, Kotak continues to be overweight. Let us begin with PSU banking space itself because that seems to be the flavour right now. Which are the names, if any, that still look very good? Will you stick your neck out and talk about only the largecap PSU banking names or is it getting a lot wider?While I cannot talk about specific names, let us discuss the PSU banking pack as a whole. Over the last year or so, there has been tailwinds in the overall banking sector and there has been improvement in terms of profitability in terms of return on assets for the bank. The second most important factor is that we are now in a scenario where credit costs have been extremely benign and then together with the news that has come in today in terms of the bond inclusion, overall it does look that from interest rate perspective and bond yield perspective, there is the much needed downside support that has come through.

Vinit Bolinjkar, Head of Research, Ventura Securities, says “the Ambuja Group offers an opportunity to enter the segment because over the next three years, we are going to see some huge capacity additions. It is a largecap stock and due to the baggage around the Adani Group, it was underperforming.” He further says, “I will go with BHEL” in capital goods space. “There is a very sweet spot for BHEL to build on this story.”Are there fresh opportunities within the cement pack wherein you would recommend a buy?I believe that the Ambuja Group offers an opportunity to enter the segment because over the next three years, we are going to see some huge capacity additions. It is a largecap stock and due to the baggage around the Adani Group, it was underperforming. But tomorrow we have the hearing and hence, I expect that once the hearing is through, better sense will prevail, investment buying will start and I expect this stock to do well in the cement sector.

Destiny 2's enigmatic vendor, Xur, continues to uphold his unpredictable nature with his assortment of Exotic items. Each week, players eagerly anticipate his arrival, as he brings a selection of Exotics, along with older legendary armor and weapons that collectors may be missing from their arsenal. Xur makes his appearance from Friday until the weekly reset, but locating him can be a challenge, as he can be found in various random locations throughout the world of Destiny 2, including inside the Tower.

Rahul Shah, VP-Equity Advisory, MOFSL, says all specialty businesses are firing up in Sun Pharma and the US business also is better vis-à-vis competitors. So, Sun Pharma remains the top bet in the entire pharma basket. I feel that in the pharma pack, one should look at Ciplas of the world.